Description
Monday, October 23, 2023 | 12:00-1:00pm
Description
Perinatal substance use is a critical public health concern and alcohol remains one of the most used substances during pregnancy. Despite risk of harm from alcohol exposure, patients often hear mixed messages in the media. In this session, we will review screening tools for alcohol use during pregnancy as well as potential fetal impacts of perinatal alcohol use. We will discuss evidence based best practices for the treatment of alcohol use disorder in the perinatal period, summarize Maine’s FASD notification requirement and review strategies for discussing alcohol use with pregnant patients.
Objectives
1. Review validated screening tools for alcohol use disorder during pregnancy as well as potential fetal impacts of perinatal alcohol use.
2. Discuss evidence based best practices for the treatment of alcohol use disorder in the perinatal period.
3. Summarize Maine’s FASD notification requirement and strategies for discussing alcohol use with pregnant patients.
Presenter: Alane O’Connor, DNP
Alane O’Connor, DNP is the director of perinatal addiction medicine at Maine Medical Center and is the medical advisor of the Maine Maternal Opioid Misuse (MaineMOM) Initiative, a 5-year, $5 million federal grant to expand access to substance use treatment for pregnant and postpartum individuals in Maine. She also co-chairs Maine’s Opioid Response Clinical Advisory Committee, which advises the Governor’s opioid response director on clinical and public policy issues. Dr. O’Connor has more than 15 years of experience in addiction medicine in a variety of settings including the design and implementation of an extended-release buprenorphine pilot at Somerset County Jail, rapid access to substance use treatment in emergency departments through Maine Medical Association’s Project RISE, as well extensive experience caring for pregnant patients with substance use disorder in both the inpatient and outpatient settings. She lectures regionally and nationally and has trained more than 100 family medicine and obstetric resident physicians. She is a core faculty member of Maine’s only addiction medicine fellowship program. Finally, she has published numerous peer reviewed articles on maternal and infant outcomes of substance exposed pregnancies including the related child welfare implications as well as the care of incarcerated pregnant patients.
Audience:
Prescribing clinicians and their teams
Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Maine Medical Education Trust and CCSME. The Maine Medical Education Trust is accredited by the Maine Medical Association Committee on Continuing Medical Education and Accreditation to provide continuing medical education for physicians.
The Maine Medical Education Trust designates this regularly scheduled series for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
*Nurses and Nurse Practitioners will be awarded a certificate of participation with a maximum of 1 AMA PRA Category 1 Credit™.
Contact Hours
1 contact hour for social workers, licensed clinical professional counselors, and behavioral health professionals.
1 contact hour for Alcohol and Drug Counselors pending approval by the Maine Board of Alcohol and Drug Counselors
1 Category I contact hour for psychologists. CCSME is a pre-approved sponsor and provider of Professional Education Activities for Psychologists.
1 contact hour CHES. CCSME is a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc.
